Clinical Trials Insight: 700030494
Phase of Trial: Phase I
Latest Information Update: 16 Jul 2010
At a glance
- Drugs TM 38837 (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors 7TM Pharma
- 16 Jul 2010 Results were reported at the 11th International Congress on Obesity.
- 20 Jan 2010 Status changed from planning to completed.
- 02 Sep 2008 This trial is expected to be inititated in the first half of 2009.